{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:22:48Z","timestamp":1740028968335,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1124\/jpet.107.128207","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T01:04:41Z","timestamp":1191978281000},"page":"214-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pemoline (2-Amino-5-phenyl-1,3-oxazol-4-one)-induced Self-Injurious Behavior: A Rodent Model of Pharmacotherapeutic Efficacy"],"prefix":"10.1016","volume":"324","author":[{"given":"Amber M.","family":"Muehlmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darragh P.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Alaverdashvili M, Kubova H, and Mares P (2005) Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav 7: 222\u2013230.","key":"10.1124\/jpet.107.128207_bib1","DOI":"10.1016\/j.yebeh.2005.04.013"},{"doi-asserted-by":"crossref","unstructured":"Allen SM, Freeman JN, and Davis WM (1998) Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome. Pharmacol Biochem Behav 59: 327\u2013330.","key":"10.1124\/jpet.107.128207_bib2","DOI":"10.1016\/S0091-3057(97)00411-5"},{"doi-asserted-by":"crossref","unstructured":"Burgess JW (1991) Relationship of depression and cognitive impairment to self-injury in borderline personality disorder, major depression, and schizophrenia. Psychiatry Res 38: 77\u201387.","key":"10.1124\/jpet.107.128207_bib3","DOI":"10.1016\/0165-1781(91)90054-S"},{"unstructured":"Caicedo C and Williams SH (2002) Risperidone improves behavior in children with autism. J Fam Pract 51: 915.","key":"10.1124\/jpet.107.128207_bib4"},{"doi-asserted-by":"crossref","unstructured":"DeLorenzo RJ, Sombati S, and Coulter DA (2000) Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41 (Suppl 1): S40\u2013S44.","key":"10.1124\/jpet.107.128207_bib5","DOI":"10.1111\/j.1528-1157.2000.tb02170.x"},{"doi-asserted-by":"crossref","unstructured":"Drago F, Contarino A, Marino R, Anzallo C, Valerio C, Rampello L, Raffaele R, and Scapagnini U (1997) Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats. Pharmacol Res 35: 17\u201325.","key":"10.1124\/jpet.107.128207_bib6","DOI":"10.1006\/phrs.1996.0101"},{"doi-asserted-by":"crossref","unstructured":"Fernandez TA, Boix F, Escorihuela RM, Yanez P, and Tobena A (1988) Sodium valproate reduces immobility in the behavioral \u201cdespair\u201d test in rats. Eur J Pharmacol 152: 1\u20137.","key":"10.1124\/jpet.107.128207_bib7","DOI":"10.1016\/0014-2999(88)90829-1"},{"doi-asserted-by":"crossref","unstructured":"Gibbs JW, III, Sombati S, DeLorenzo RJ, and Coulter DA (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (Suppl 1): S10\u2013S16.","key":"10.1124\/jpet.107.128207_bib8","DOI":"10.1111\/j.1528-1157.2000.tb02164.x"},{"doi-asserted-by":"crossref","unstructured":"Goldsmith TB, Shapira NA, and Keck PE Jr (1999) Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry 156: 660\u2013661.","key":"10.1124\/jpet.107.128207_bib9","DOI":"10.1176\/ajp.156.4.660a"},{"doi-asserted-by":"crossref","unstructured":"Guneli E, Karabay Yavasoglu NU, Apaydin S, Uyar M, and Uyar M (2007) Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain. Pharmacol Biochem Behav 88: 9\u201317.","key":"10.1124\/jpet.107.128207_bib10","DOI":"10.1016\/j.pbb.2007.06.006"},{"unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.","key":"10.1124\/jpet.107.128207_bib11"},{"doi-asserted-by":"crossref","unstructured":"Janowsky DS, Barnhill LJ, Shetty M, and Davis JM (2005a) Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults. J Clin Psychopharmacol 25: 19\u201325.","key":"10.1124\/jpet.107.128207_bib12","DOI":"10.1097\/01.jcp.0000150218.51433.7b"},{"doi-asserted-by":"crossref","unstructured":"Janowsky DS, Shetty M, Barnhill J, Elamir B, and Davis JM (2005b) Serotonergic antidepressant effects on aggressive, self-injurious and destructive\/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial. Int J Neuropsychopharmacol 8: 37\u201348.","key":"10.1124\/jpet.107.128207_bib13","DOI":"10.1017\/S146114570400481X"},{"doi-asserted-by":"crossref","unstructured":"Kies SD and Devine DP (2004) Self-injurious behaviour: a comparison of caffeine and pemoline models in rats. Pharmacol Biochem Behav 79: 587\u2013598.","key":"10.1124\/jpet.107.128207_bib14","DOI":"10.1016\/j.pbb.2004.09.010"},{"doi-asserted-by":"crossref","unstructured":"King BH, Au D, and Poland RE (1993) Low dose naltrexone inhibits pemoline-induced self-biting behavior in prepubertal rats. J Child Adol Psychopharmacol 3: 71\u201379.","key":"10.1124\/jpet.107.128207_bib15","DOI":"10.1089\/cap.1993.3.71"},{"doi-asserted-by":"crossref","unstructured":"Kus I, Ogeturk M, Oner H, Sahin S, Yekeler H, and Sarsilmaz M (2005) Protective effects of melatonin against carbon tetrachloride-induced hepatotoxicity in rats: a light microscopic and biochemical study. Cell Biochem Funct 23: 169\u2013174.","key":"10.1124\/jpet.107.128207_bib16","DOI":"10.1002\/cbf.1136"},{"doi-asserted-by":"crossref","unstructured":"Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, and Janssen PA (1988) Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 247: 661\u2013670.","key":"10.1124\/jpet.107.128207_bib17","DOI":"10.1016\/S0022-3565(25)13416-2"},{"doi-asserted-by":"crossref","unstructured":"Masi G (2004) Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS Drugs 18: 1031\u20131052.","key":"10.1124\/jpet.107.128207_bib18","DOI":"10.2165\/00023210-200418140-00006"},{"doi-asserted-by":"crossref","unstructured":"McLean MJ and MacDonald RL (1986) Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 237: 1001\u20131011.","key":"10.1124\/jpet.107.128207_bib19","DOI":"10.1016\/S0022-3565(25)24966-7"},{"unstructured":"Molina VA and Orsingher OA (1981) Effects of Mg-pemoline on the central catecholaminergic system. Arch Int Pharmacodyn Ther 251: 66\u201379.","key":"10.1124\/jpet.107.128207_bib20"},{"doi-asserted-by":"crossref","unstructured":"Mueller K and Hsiao S (1980) Pemoline-induced self-biting in rats and self-mutilation in the deLange syndrome. Pharmacol Biochem Behav 13: 627\u2013631.","key":"10.1124\/jpet.107.128207_bib21","DOI":"10.1016\/0091-3057(80)90003-9"},{"doi-asserted-by":"crossref","unstructured":"Mueller K and Nyhan WL (1982) Pharmacologic control of pemoline induced self-injurious behavior in rats. Pharmacol Biochem Behav 16: 957\u2013963.","key":"10.1124\/jpet.107.128207_bib22","DOI":"10.1016\/0091-3057(82)90052-1"},{"doi-asserted-by":"crossref","unstructured":"Nau H and Loscher W (1982) Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse. J Pharmacol Exp Ther 220: 654\u2013659.","key":"10.1124\/jpet.107.128207_bib23","DOI":"10.1016\/S0022-3565(25)32998-8"},{"doi-asserted-by":"crossref","unstructured":"Primeau F and Fontaine R (1987) Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy. Can J Psychiatry 32: 699\u2013701.","key":"10.1124\/jpet.107.128207_bib24","DOI":"10.1177\/070674378703200813"},{"doi-asserted-by":"crossref","unstructured":"Primrose DA (1979) Treatment of self-injurious behavior with a GABA (gammaaminobutyric acid) analogue. J Ment Def Res 23: 163\u2013173.","key":"10.1124\/jpet.107.128207_bib25","DOI":"10.1111\/j.1365-2788.1979.tb00991.x"},{"doi-asserted-by":"crossref","unstructured":"Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, and Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u201catypical\u201d opioid analgesic. J Pharmacol Exp Ther 260: 275\u2013285.","key":"10.1124\/jpet.107.128207_bib26","DOI":"10.1016\/S0022-3565(25)11227-5"},{"doi-asserted-by":"crossref","unstructured":"Razzak A, Fujiwara M, Oishi MR, and Ueki S (1977) Possible involvement of a central noradrenergic system in automutilation induced by clonidine in mice. Jpn J Pharmacol 27: 145\u2013152.","key":"10.1124\/jpet.107.128207_bib27","DOI":"10.1254\/jjp.27.145"},{"doi-asserted-by":"crossref","unstructured":"Robertson MM, Trimble MR, and Lees AJ (1989) Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature. Psychol Med 19: 611\u2013625.","key":"10.1124\/jpet.107.128207_bib28","DOI":"10.1017\/S0033291700024211"},{"doi-asserted-by":"crossref","unstructured":"Rojahn J and Esbensen AJ (2002) Epidemiology of self-injurious behavior in mental retardation: a review, in Self-Injurious Behavior: Gene-Brain-Behavior Relationships (Schroeder SR, Oster-Granite ML, and Thompson T eds) pp 41\u201377, American Psychological Association, Washington, DC.","key":"10.1124\/jpet.107.128207_bib29","DOI":"10.1037\/10457-003"},{"doi-asserted-by":"crossref","unstructured":"Ruedrich S, Swales TP, Fossaceca C, Toliver J, and Rutkowski A (1999) Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: a retrospective review. J Intellect Disabil Res 43: 105\u2013111.","key":"10.1124\/jpet.107.128207_bib30","DOI":"10.1046\/j.1365-2788.1999.00193.x"},{"unstructured":"Sandman CA, Barron JL, and Colman H (1990) An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. Am J Ment Retard 95: 93\u2013102.","key":"10.1124\/jpet.107.128207_bib31"},{"doi-asserted-by":"crossref","unstructured":"Shapira NA, Lessig M, Murphy TK, Annis AM, and Lazoritz M (2003) Evaluation of open-label topiramate for scar therapy. Dermatol Online J 9: 3.","key":"10.1124\/jpet.107.128207_bib32","DOI":"10.5070\/D38960F67R"},{"doi-asserted-by":"crossref","unstructured":"Shapira NA, Lessig MC, Murphy TK, Driscoll DJ, and Goodman WK (2002) Topiramate attenuates self-injurious behaviour in Prader-Willi syndrome. Int J Neuropsychopharmacol 5: 141\u2013145.","key":"10.1124\/jpet.107.128207_bib33","DOI":"10.1017\/S1461145702002833"},{"doi-asserted-by":"crossref","unstructured":"Shapira NA, McConville BJ, Pagnucco ML, Norman AB, and Keck PE Jr (1997) Novel use of tramadol hydrochloride in the treatment of Tourette\u2019s syndrome. J Clin Psychiatry 58: 174\u2013175.","key":"10.1124\/jpet.107.128207_bib34","DOI":"10.4088\/JCP.v58n0407b"},{"doi-asserted-by":"crossref","unstructured":"Turner CA and Lewis MH (2002) Dopaminergic mechanisms in self-injurious behavior and related disorders, in Self-Injurious Behavior: Gene-Brain-Behavior Relationships (Schroeder SR, Oster-Granite ML, and Thompson T eds) pp 165\u2013179, American Psychological Association, Washington, DC.","key":"10.1124\/jpet.107.128207_bib35","DOI":"10.1037\/10457-011"},{"doi-asserted-by":"crossref","unstructured":"Turner CA, Panksepp J, Bekkedal M, Borkowski C, and Burgdorf J (1999) Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior. Pharmacol Biochem Behav 63: 361\u2013366.","key":"10.1124\/jpet.107.128207_bib36","DOI":"10.1016\/S0091-3057(99)00018-0"},{"doi-asserted-by":"crossref","unstructured":"Wagner GC, Avena N, Kita T, Nakashima T, Fisher H, and Halladay AK (2004) Risperidone reduction of amphetamine-induced self-injurious behavior in mice. Neuropharmacology 46: 700\u2013708.","key":"10.1124\/jpet.107.128207_bib37","DOI":"10.1016\/j.neuropharm.2003.11.009"},{"doi-asserted-by":"crossref","unstructured":"White HS, Brown SD, Woodhead JH, Skeen GA, and Wolf HH (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28: 167\u2013179.","key":"10.1124\/jpet.107.128207_bib38","DOI":"10.1016\/S0920-1211(97)00045-4"},{"doi-asserted-by":"crossref","unstructured":"Willemsen-Swinkels SHN, Buitelaar JK, Nijhof GJ, and Van Engeland H (1995) Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults: double-blind placebo-controlled studies. Arch Gen Psychiatry 52: 766\u2013773.","key":"10.1124\/jpet.107.128207_bib39","DOI":"10.1001\/archpsyc.1995.03950210060011"},{"doi-asserted-by":"crossref","unstructured":"Winchel RM and Stanley M (1991) Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 148: 306\u2013317.","key":"10.1124\/jpet.107.128207_bib40","DOI":"10.1176\/ajp.148.3.306"},{"doi-asserted-by":"crossref","unstructured":"Zeise ML, Kasparow S, and Zieglgansberger W (1991) Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res 544: 345\u2013348.","key":"10.1124\/jpet.107.128207_bib41","DOI":"10.1016\/0006-8993(91)90078-A"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524342259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524342259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.128207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:29:26Z","timestamp":1740004166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524342259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0022356524342259"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.128207","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemoline (2-Amino-5-phenyl-1,3-oxazol-4-one)-induced Self-Injurious Behavior: A Rodent Model of Pharmacotherapeutic Efficacy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.128207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}